April 09, 2026

The molecular research “booster” evolves: SIMPLAIX collaboration starts the next phase

The molecular research “booster” evolves: SIMPLAIX collaboration starts the next phase

Computer simulations and Artificial Intelligence are the main pillars of the “SIMPLAIX” collaboration, initiated by the Heidelberg Institute for Theoretical Studies (HITS). Together with colleagues from Heidelberg University and Karlsruhe Institute of Technology (KIT), HITS researchers are addressing challenges in the simulation of biomolecules and molecular materials by pooling their expertise in multiscale computer simulation and machine learning. Established in 2021, SIMPLAIX has been successfully evaluated and has now started its second phase, with the Max Planck Institute for Polymer Research (MPIP) as an additional partner. The initiative is funded by the Klaus Tschira Foundation.

Molecular mechanisms and the rational design of molecules and materials for specific applications have traditionally been explored using physics-based modeling and simulations. These methods have revolutionized modern science and technology. However, they reach their limits when it comes to mapping, exploring, and analyzing the infinitely complex and variable structures and properties of molecular systems over the wide range of relevant scales. Here, data-driven and machine learning methods offer a promising approach.

This is why the Heidelberg Institute for Theoretical Studies (HITS), Heidelberg University, and the Karlsruhe Institute of Technology (KIT) launched the SIMPLAIX collaboration in 2021. They combine the expertise of the three partner institutions to address the challenges of bridging scales in simulating biomolecules and molecular materials through multiscale simulation and machine learning.
Along with collaborative research projects, the first years saw well-attended international workshops and many internal meetings, a remarkable number of publications and several awards for SIMPLAIX PIs, among them an ERC Advanced Grant and a DFG Heinz-Maier Leibnitz Prize.

After a successful evaluation, SIMPLAIX has started its second phase, gaining additional strength by the addition of a new associate partner: The Max Planck Institute for Polymer research (MPIP) in Mainz. With 10 principal investigators (PIs) and 8 projects, SIMPLAIX will evolve and broaden the cross-disciplinary and cross-institutional scientific collaborations in the research projects.

In addition, the highly successful SIMPLAIX workshop series will continue in May 2026. The registration is open: https://simplaix-workshop2026.h-its.org/.  This year’s workshop will be jointly organized with RTG 2450, a DFG-funded research graduate school at KIT.

SIMPLAIX is coordinated by HITS researcher Rebecca Wade, supported by HITS Alumna Frauke Gräter, now Director at the MPIP. The Klaus Tschira Foundation provides financial support which is complemented by the four participating institutions.

More information: www.simplaix.org

Scientific contact:
Prof. Dr. Rebecca Wade
Molecular and Cellular Modeling Group (MCM)
Heidelberg Institute for Theoretical Studies (HITS),

Press contact:
Angela Michel
Head of Communications
Heidelberg Institute for Theoretical Studies (HITS)
E-Mail: angela.michel@h-its.org
www.h-its.org

Our latest News

discover more
Interdisciplinary Care for Elderly Trauma Patients: Heidelberg University Hospital’s Center for Geriatric Trauma Receives Certification

Interdisciplinary Care for Elderly Trauma Patients: Heidelberg University Hospital’s Center for Geriatric Trauma Receives Certification

The German Society for Trauma Surgery has jointly certified the Department of Trauma and Reconstructive Surgery at Heidelberg University Hospital (UKHD) and Agaplesion Bethanien Hospital Heidelberg as a Geriatric Trauma Center. The certification recognizes the outstanding care provided to elderly trauma patients at UKHD and underscores the great importance of interdisciplinary geriatric medicine. Full text […]

Tony Hyman starts as EMBL Director General

Tony Hyman starts as EMBL Director General

Former EMBL group leader returns to lead the organisation’s six sites at a time of change and opportunity in life sciences EMBL welcomes its new Director General, Tony Hyman, who will take up the mandate of leading EMBL’s six sites as the organisation enters its next phase. Hyman succeeds Interim Director Ewan Birney, who assumed leadership […]

New Mouse Model: Rhabdomyosarcoma GEMM

New Mouse Model: Rhabdomyosarcoma GEMM

We are very proud to be a part of a joint, international effort to develop a genetically engineered mouse model (GEMM) for the understudied pediatric cancer, alveolar rhabdomyosarcoma (aRMS). This model, which has been deposited at JAX (strain 041178), will accelerate the development of living-saving therapies for children with aRMS. This model was developed as a […]

GET IN TOUCH

Stay Updated with bioRN’s Newsletter

Sign up for our newsletter to discover more!
* required

BioRN (BioRN Network e.V. and BioRN Cluster Management GmbH) will use the information you provide on this form to be in touch with you and to provide updates and marketing. Please let us know all the ways you would like to hear from us:

You can update your subscription preferences or unsubscribe at any time. Just follow the unsubscribe or update link in the footer of automated emails you receive from us, or by contacting us at info@biorn.org. We will treat your information with respect. For more information about our privacy practices please visit our website: www.biorn.org. By clicking below, you agree that we may process your information in accordance with these terms.

We use Mailchimp as our marketing platform. By clicking below to subscribe, you acknowledge that your information will be transferred to Mailchimp for processing. Learn more about Mailchimp's privacy practices.

Intuit Mailchimp